Brief: Castle Biosciences Q1 Basic EPS USD -0.9
05/05/2025 21:06
May 05 (Reuters) - Castle Biosciences Q1 revenue USD 87.988 million vs. IBES estimate USD 80.3 million. Q1 operating income USD -27.928 million Q1 operating expenses USD 115.916 million Q1 pretax profit USD -26.271 million vs. IBES estimate USD -4.51 million Q1 net income USD -25.848 million vs. IBES estimate USD -5.04 million
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million